Netherlands· NL-2ecb4381f807
Fampyra 10 mg tabletten met verlengde afgifte
A fampridine product containing fampridine, registered in Netherlands by Merz Therapeutics GmbH. The same ATC class is registered in 15 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Fampridine is registered in 15 of 19 countries.
Countries holding a registration under ATC N07XX07 (fampridine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Fampridine · ATC N07XX07
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of fampridine costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $2.00 in France to $11.20 in Switzerland — a ×5.6 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Fampridine · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$11.20
- FR France$2.00
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- FAMPRIDINE
- Manufacturer
- Merz Therapeutics GmbH
- Country
- Netherlands (NL)
- ATC code
- N07XX07
- ATC class
- Fampridine
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/11/699
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
32 interactions on record for fampridine.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fampridine · interactions on record
32 records
- 4 severe
- 28 moderate
Most severe, free to view
- BupropionN06AX12severe
- BupropionN07BA02severe
- IohexolV08AB02severe
- IopamidolV08AB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fampridine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFAMPRIDIN SANDOZSandoz s.r.o., Praha
- FinlandFampridin ZentivaZentiva, k.s.
- SpainFAMPRIDINA ACCORD 10 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFGAccord Healthcare S.L.U.
- FranceFAMPRIDINE ACCORD 10 mg, comprimé à libération prolongéeACCORD HEALTHCARE (ESPAGNE)
- SwedenFampridin Medical Valley 10 mg DepottablettMedical Valley Invest AB
- IcelandFampridin Medical ValleyMedical Valley Invest AB
- PolandFampridine AccordAccord Healthcare S.L.U.
- NorwayFampridine AccordAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Fampridin Neuraxpharm, Fampridin Ratiopharm
- Cyprus · Fampridine Sandoz, Fampridine Viatris
- Czechia · Fampridin Sandoz, Fampridine Abdi
- Germany · Fampridin Abdi, Fampridin Abz
- Denmark · Fampridin "neuraxpharm", Fampridin Medical Valley
- Spain · Fampridina Aurovitas, Fampridina Qualigen
- Finland · Fampridin Medical Valley, Fampridin Zentiva
- France · Fampridine Arrow, Fampridine Eg
- United Kingdom (Northern Ireland) · Elupria, Fampridine Abdi
- Greece · Fadisa, Fampridine Sandoz
- Croatia · Fampridin Sandoz, Fampridin Teva
- Hungary · Fampridine Rontis
- Ireland · Fampridine Rowa
- Iceland · Fampridin Medical Valley, Fampridin Neuraxpharm
- Italy · Fampridina Abdi
- Liechtenstein · Fampridine Accord, Fampyra
- Luxembourg · Fampridine Eg
- Malta · Fampridine Viatris
- Norway · Fampridin Medical Valley, Fampridin Neuraxpharm
- Poland · Fampridine Sandoz, Fampridine Teva
- Portugal · Fampridina Ascend, Fampridina Generis
- Sweden · Fampridin Medical Valley, Fampridin Zentiva
- Slovenia · Fampridin Stada, Fampridin Teva
- Slovakia · Fampridín Teva, Fampridine Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f6a4dc70-9124-4471-a12f-2fe6e7ee2105 GET /v1/drugs/f6a4dc70-9124-4471-a12f-2fe6e7ee2105?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet met verlengde afgifte",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/fampyra-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Fampridine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp106803",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"HYPROMELLOSE (E 464)",
"MACROGOL 400",
"MAGNESIUMSTEARAAT (E 470b)",
"SILICIUMDIOXIDE (E 551)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"FAMPRIDINE"
],
"leaflet_url": null,
"authorised_at": "2011/07/20",
"procedure_number": "EMEA/H/C/002097",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/11/699",
"additional_monitoring": "N"
}See everything about fampridine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.